Acquired Perforating Dermatosis: A Disorder Treatable with Mycophenolate Mofetil.
Journal
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
ISSN: 1319-2442
Titre abrégé: Saudi J Kidney Dis Transpl
Pays: Saudi Arabia
ID NLM: 9436968
Informations de publication
Date de publication:
01 Mar 2023
01 Mar 2023
Historique:
medline:
26
12
2023
pubmed:
26
12
2023
entrez:
26
12
2023
Statut:
ppublish
Résumé
Acquired perforating dermatosis (APD) is an adult skin disease characterized by an umbilicated papulonodular rash with transepidermal elimination of dermal components such as collagen and/or elastin. It is frequently associated with multiple medications and diseases such as diabetes and chronic renal failure. It is a disabling disease with severe pruritus in 83.3% of cases and generalized ulcerating lesions that are associated with infections and scarring. Nearly 10% of renal patients are affected. Supportive measurements of disease activity and previous medications failed to halt its natural progression. In our study, we documented significant improvements in the severity of the disease as measured by the eczema area and severity index (EASI), in 32 patients with the renal disease through the use of mycophenolate mofetil (MMF), with EASI decreasing from 31 [interquartile range (IQR) = 4] to 3 (IQR = 4) by the 3rd month. Moreover, such changes persisted for up to 2 years despite a decrease in the dose of MMF to half after 1 year. In conclusion, our study showed that MMF is a safe and effective immunosuppressive drug for short- and intermediate-term therapy of severe APD and confirmed its autoimmune etiology.
Identifiants
pubmed: 38146723
doi: 10.4103/1319-2442.391892
pii: 00936703-202334020-00006
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
142-146Informations de copyright
Copyright © 2023 Copyright: © 2023 Saudi Journal of Kidney Diseases and Transplantation.
Références
Mehregan AH, Coskey RJ. Perforating folliculitis. Arch Dermatol 1968;97:394-9.
Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol 1989;125:1074-8.
Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol 1994;30:575-80.
Kawakami T, Akiyama M, Ishida-Yamamoto A, et al. Clinical practice guide for the treatment of perforating dermatosis. J Dermatol 2020;47:1374-82.
Kim SW, Kim MS, Lee JH, et al. A clinico- pathologic study of thirty cases of acquired perforating dermatosis in Korea. Ann Dermatol 2014;26:162-71.
Lukács J, Schliemann S, Elsner P. Treatment of acquired reactive perforating dermatosis - A systematic review. J Dtsch Dermatol Ges 2018;16:825-42.
Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Acquired reactive perforating collagenosis: Current status. J Dermatol 2010;37:585-92.
Gambichler T, Birkner L, Stücker M, Othlinghaus N, Altmeyer P, Kreuter A. Up- regulation of transforming growth factor-beta3 and extracellular matrix proteins in acquired reactive perforating collagenosis. J Am Acad Dermatol 2009;60:463-9.
Fujimoto N, Akagi A, Tajima S, et al. Expression of the 67-kDa elastin receptor in perforating skin disorders. Br J Dermatol 2002;146:74-9.
Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. EASI evaluator group. Exp Dermatol 2001;10:11-8.
Wagner G, Sachse MM. Acquired reactive perforating dermatosis. J Dtsch Dermatol Ges 2013;11:723-9, 723-30.
Imam TH, Patail H, Khan N, Hsu PT, Cassarino DS. Acquired perforating dermatosis in a patient on peritoneal dialysis: A case report and review of the literature. Case Rep Nephrol 2018;2018:5953069.
Sollinger HW. Mycophenolates in transplan-tation. Clin Transplant 2004;18:485-92.
Stassen PM, Kallenberg CG, Stegeman CA. Use of mycophenolic acid in non-transplant renal diseases. Nephrol Dial Transplant 2007;22:1013-9.